Scripta Insights Raises $17 Million in Funding

Scripta Insights has successfully raised $17 million in Series B funding, led by Aquiline, bringing its total funding to $42 million. The company, which focuses on providing pharmacy navigation solutions for self-insured employers and health plans, aims to enhance transparency and empower consumers in the medication purchasing process. Scripta's platform includes tools like Rx Navigator, which offers personalized savings reports and alternative medication options, and Rx Monitor, which assists plan sponsors in managing their prescription costs. This funding comes after Scripta reported a revenue increase of over 100% in 2024, indicating strong market demand. The new capital will support the company's expansion into health plan and Medicare Advantage markets, while also enhancing its platform's capabilities. CEO Eric Levin emphasized the mission to transform how Americans shop for prescription drugs, highlighting that their solutions have already generated significant savings for users.